Allarity Therapeutics Inc (NASDAQ:ALLR) shares, rose in value, with the stock price up by 5.78% to the previous day’s close as strong demand from buyers drove the stock to $0.25.
Actively observing the price movement in the last trading, the stock closed the session at $0.23. The value of beta (5-year monthly) was 0.24. Referring to stock’s 52-week performance, its high was $154.40, and the low was $0.23. On the whole, ALLR has fluctuated by -39.90% over the past month.
As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.53, which is expected to increase to -$0.28 for fiscal year -$1.43 and then to about -$1.52 by fiscal year 2025. Data indicates that the EPS growth is expected to be 86.10% in 2025, while the next year’s EPS growth is forecast to be -6.30%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that ALLR’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of ALLR currently trading nearly -27.24% and -36.31% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 24.52, while the 7-day volatility ratio is showing 18.35% which for the 30-day chart, stands at 10.98%. Furthermore, Allarity Therapeutics Inc (ALLR)’s beta value is 0.23, and its average true range (ATR) is 0.03.
A comparison of Allarity Therapeutics Inc (ALLR) with its peers suggests the former has fared considerably weaker in the market. ALLR showed an intraday change of 5.78% in last session, and over the past year, it shrunk by -99.65%%.
Data on historical trading for Allarity Therapeutics Inc (NASDAQ:ALLR) indicates that the trading volumes over the past 10 days have averaged 0.27 million and over the past 3 months, they’ve averaged 143.59K. According to company’s latest data on outstanding shares, there are 5.89 million shares outstanding.
Nearly 11.12% of Allarity Therapeutics Inc’s shares belong to company insiders and institutional investors own 0.94% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.61 million shares as on Mar 15, 2024, resulting in a short ratio of 4.93. According to the data, the short interest in Allarity Therapeutics Inc (ALLR) stood at 9.94% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 0.64 million. The stock has fallen by -55.18% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ALLR stock heading into the next quarter.
